ACM
IDXX icon

Aster Capital Management’s Idexx Laboratories IDXX Stock Holding History

Aster Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.9K Sell
76
-18
-19% -$11.5K 0.01% 500
2025
Q4 		$63.6K Sell
94
-101
-52% -$68.8K 0.03% 424
2025
Q3 		$125K Sell
195
-3,735
-95% -$2.27M 0.06% 343
2025
Q2 		$2.11M Buy
3,930
+3,699
+1,601% +$1.77M 0.48% 49
2025
Q1 		$101K Buy
+231
New +$100K 0.02% 651

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aster Capital Management's IDXX Position: Q1 2026 in Review

Aster Capital Management reduced its Idexx Laboratories (IDXX) stake by 19% in Q1 2026, selling an estimated $11.5K and leaving 76 shares worth $31.9K. The position accounts for 0.01% of the portfolio, ranked #500.

Aster Capital Management first reported a position in IDXX in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.11M in Q2 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Aster Capital Management held 76 shares of Idexx Laboratories worth $31.9K as of Q1 2026.
  • Aster Capital Management sold 18 Idexx Laboratories shares in Q1 2026, an estimated $11.5K.
  • Idexx Laboratories made up 0.01% of Aster Capital Management's portfolio in Q1 2026, its #500 holding.
  • Aster Capital Management first reported a position in Idexx Laboratories in Q1 2025 and has held it in 5 quarters since.
  • Aster Capital Management's Idexx Laboratories position peaked at $2.11M in Q2 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.